标题
Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus
作者
关键词
-
出版物
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Volume 37, Issue 11, Pages 108614
出版商
Elsevier BV
发表日期
2023-09-25
DOI
10.1016/j.jdiacomp.2023.108614
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Research on Type 2 Diabetes: A Promising and Multifaceted Landscape
- (2022) Fernando Gómez-Peralta et al. Journal of Clinical Medicine
- Angiogenesis–Browning Interplay Mediated by Asprosin-Knockout Contributes to Weight Loss in Mice with Obesity
- (2022) Tingting Yin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An overview of autophagy: Mechanism, regulation and research progress
- (2021) Weiya Cao et al. BULLETIN DU CANCER
- Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue
- (2021) Yanli Miao et al. JOURNAL OF ENDOCRINOLOGY
- High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
- (2021) Tao Hong et al. International Journal of Endocrinology
- Angiogenesis in Adipose Tissue: The Interplay Between Adipose and Endothelial Cells
- (2021) Jacqueline Herold et al. Frontiers in Physiology
- Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
- (2021) Aijun Jiang et al. Diabetology & Metabolic Syndrome
- Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
- (2021) Kiran Shabir et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Autophagy in major human diseases
- (2021) Daniel J Klionsky et al. EMBO JOURNAL
- Insulin resistance and insulin sensitizing agents
- (2021) Lucia Mastrototaro et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity
- (2021) Lu-Jie Liu et al. World Journal of Pediatrics
- IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021
- (2021) Katherine Ogurtsova et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Interpreting global trends in type 2 diabetes complications and mortality
- (2021) Mohammed K. Ali et al. DIABETOLOGIA
- Sarcopenia, frailty and type 2 diabetes mellitus (Review)
- (2021) Hiroki Nishikawa et al. Molecular Medicine Reports
- New insights into β-cell failure, regeneration and replacement
- (2021) Mostafa Bakhti et al. Nature Reviews Endocrinology
- Insulin Resistance: From Mechanisms to Therapeutic Strategies
- (2021) Shin-Hae Lee et al. Diabetes & Metabolism Journal
- Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study
- (2020) Lieqiang Zhong et al. PLACENTA
- Asprosin promotes β‐cell apoptosis by inhibiting the autophagy of β‐cell via AMPK‐mTOR pathway
- (2020) Rui Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
- (2020) Carol Wysham et al. POSTGRADUATE MEDICINE
- Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease
- (2020) Fan Ke et al. CYTOKINE
- Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin
- (2020) Nevzat Gozel et al. Endokrynologia Polska
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus
- (2019) Yakup Baykus et al. PEPTIDES
- The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities
- (2019) Wei Ying et al. Nature Reviews Endocrinology
- Leptin, cardiovascular diseases and type 2 diabetes mellitus
- (2018) Niki Katsiki et al. ACTA PHARMACOLOGICA SINICA
- Genomic insights into the causes of type 2 diabetes
- (2018) Claudia Langenberg et al. LANCET
- Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
- (2018) Yuren Wang et al. MEDIATORS OF INFLAMMATION
- Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
- (2018) Xing Li et al. MEDIATORS OF INFLAMMATION
- Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments
- (2018) Jacintha O’Sullivan et al. Nature Reviews Gastroenterology & Hepatology
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- Targeting adipose tissue in the treatment of obesity-associated diabetes
- (2016) Christine M. Kusminski et al. NATURE REVIEWS DRUG DISCOVERY
- Lipodystrophy: Syndrome of severe insulin resistance
- (2015) Shagun Bindlish et al. POSTGRADUATE MEDICINE
- Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3′ end of FBN1 gene
- (2014) Adeline Jacquinet et al. European Journal of Medical Genetics
- Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
- (2014) Ahmad Haider et al. International Journal of Endocrinology
- Severe congenital lipodystrophy and a progeroid appearance: Mutation in the penultimate exon ofFBN1causing a recognizable phenotype
- (2013) Toshiki Takenouchi et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Disparities in Diabetes: The Nexus of Race, Poverty, and Place
- (2013) Darrell J. Gaskin et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Progeroid facial features and lipodystrophy associated with a novel splice site mutation in the final intron of the FBN1 gene
- (2011) Denise Horn et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3′ end of the FBN1 gene
- (2011) Jack Goldblatt et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3′ terminus of the FBN1-gene
- (2010) Luitgard M. Graul-Neumann et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation